| Angina pectoris stable | Chairperson(s) : |
| Angina pectoris stable | Chairperson(s) : J M Knuuti (Turku, FI), F E Rademakers (Leuven, BE) |
| Angina pectoris stable | Chairperson(s) : JS Hochman (New York, US), M Imazio (Torino, IT) |
| Angina pectoris stable | Chairperson(s) : R Bugiardini (Bologna, IT), JC Nicolau (Sao Paulo, BR) |
| Angina pectoris stable | Chairperson(s) : G A Lanza (Rome, IT), C Mannheimer (Goteborg, SE) |
| Angina pectoris stable | Chairperson(s) : J Fernandes E Fernandes (Lisbon, PT), P H Kolh (Liege, BE) |
| Angina pectoris stable | Chairperson(s) : V Fuster (New York, US), J L Zamorano Gomez (Madrid, ES) |
| Angina pectoris stable | Chairperson(s) : A J Camm (London, GB) |
| Angina pectoris stable | Chairperson(s) : J L Lopez-Sendon (Madrid, ES), A J Camm (London, GB) |
| Angina pectoris stable | Chairperson(s) : W Wojakowski (Katowice, PL), G Berkenboom (Bruxelles, BE) |
| Angina pectoris unstable | Chairperson(s) : |
| Angina pectoris unstable | Chairperson(s) : H Bueno (Madrid, ES), C J M Vrints (Edegem, BE) |
| Angina pectoris unstable | Chairperson(s) : J-P Bassand (Besancon Cedex, FR), C W Hamm (Bad Nauheim, DE) |
| Angina pectoris unstable | Chairperson(s) : J C Kaski (London, GB), H D White (Auckland, NZ) |
| Antithrombotic agents | Chairperson(s) : G Montalescot (Paris, FR), R W Nesto (Burlington, US) |
| Antithrombotic agents | Chairperson(s) : F J Neumann (Bad Krozingen, DE), D Ardissino (Parma, IT) |
| Antithrombotic agents | Chairperson(s) : AP Kappetein (Rotterdam, NL), K A A Fox (Edinburgh, GB) |
| Antithrombotic agents | Chairperson(s) : FWA Verheugt (Amsterdam, NL), G Montalescot (Paris, FR) |
| Antithrombotic agents | Chairperson(s) : F Andreotti (Rome, IT), N Danchin (Paris, FR) |
| Antithrombotic agents | Chairperson(s) : M Tubaro (Rome, IT), C J M Vrints (Edegem, BE) |
| Antithrombotic agents | Chairperson(s) : J-Y Le Heuzey (Paris, FR), K A A Fox (Edinburgh, GB) |
| Aorta, peripheral arterial and venous surgery | Chairperson(s) : T A F Folliguet (Paris, FR), M Zembala (Zabrze, PL) |
| Aortic valve disease | Chairperson(s) : |
| Aortic valve disease | Chairperson(s) : |
| Aortic valve disease | Chairperson(s) : |
| Aortic valve disease | Chairperson(s) : A Vahanian (Paris, FR), V Falk (Zurich, CH) |
| Aortic valve disease | Chairperson(s) : R Rosenhek (Vienna, AT), C M Otto (Seattle, US) |
| Aortic valve disease | Chairperson(s) : N Sinha (Lucknow, IN), S Rahimtoola (Los Angeles, US) |
| Aortic valve disease | Chairperson(s) : C Gohlke-Baerwolf (Ballrechten-Dottingen, DE), P Tornos Mas (Barcelona, ES) |
| Aortic valve disease | Chairperson(s) : A Vahanian (Paris, FR) |
| Aortic valve disease | Chairperson(s) : P Trigo Trindade (Basel, CH), M J Antunes (Coimbra, PT) |
| Aortic valve disease | Chairperson(s) : C W Hamm (Bad Nauheim, DE), E M Tuzcu (Cleveland, US) |
| Aortic valve disease | Chairperson(s) : B Iung (Paris Cedex 18, FR), A Vahanian (Paris, FR) |
| CAD and comorbidities | Chairperson(s) : |
| CAD and comorbidities | Chairperson(s) : J-P Bassand (Besancon Cedex, FR), M Pfeffer (Boston, US) |
| CAD and comorbidities | Chairperson(s) : J P Ribeiro (Porto Alegre, BR), F Ruschitzka (Zurich, CH) |
| CAD and comorbidities | Chairperson(s) : F J Pinto (Lisbon, PT), K M Fox (London, GB) |
| CAD and comorbidities | Chairperson(s) : J Kautzner (Prague, CZ), M H Crawford (San Francisco, US) |
| CAD and comorbidities | Chairperson(s) : S D Wiviott (Boston, US), J-P Bassand (Besancon Cedex, FR) |
| Invasive coronary imaging | Chairperson(s) : |
| Invasive coronary imaging | Chairperson(s) : |
| Invasive coronary imaging | Chairperson(s) : M Ostojic (Belgrade, RS), M M Degertekin (Istanbul, TR) |
| Invasive coronary imaging | Chairperson(s) : F J Pinto (Lisbon, PT), I M Pinto (Sao Paulo, BR) |
| Invasive coronary imaging | Chairperson(s) : B Merkely (Budapest, HU), E Regar (Rotterdam, NL) |
| Non coronary cardiac interventions | Chairperson(s) : |
| Non coronary cardiac interventions | Chairperson(s) : |
| Non coronary cardiac interventions | Chairperson(s) : M Endres (Berlin, DE), A Gaspardone (Rome, IT) |
| Non coronary cardiac interventions | Chairperson(s) : F R Eberli (Zurich, CH), D Himbert (Paris, FR) |
| Non coronary cardiac interventions | Chairperson(s) : A Vahanian (Paris, FR), NM Moat (London, GB) |
| PCI: procedural complications | Chairperson(s) : |
| PCI: procedural complications | Chairperson(s) : E Eeckhout (Lausanne, CH), T Raina (Sheffield, GB) |
| PCI: procedural complications | Chairperson(s) : E Eeckhout (Lausanne, CH), Y Han (Shenyang, CN) |
| PCI: procedural complications | Chairperson(s) : B Scheller (Homburg/Saar, DE), L M Goncalves (Coimbra Codex, PT) |
| PCI: procedural complications | Chairperson(s) : L Dean (Seattle, US), C Di Mario (London, GB) |
| PCI: procedural complications | Chairperson(s) : S James (Uppsala, SE), D P Foley (Dublin 3, IE) |
| Thrombolysis and mechanical reperfusion | Chairperson(s) : |
| Invasive coronary imaging | Chairperson(s) : |
| Invasive coronary imaging | Chairperson(s) : |
| Invasive coronary imaging | Chairperson(s) : M Ostojic (Belgrade, RS), M M Degertekin (Istanbul, TR) |
| Invasive coronary imaging | Chairperson(s) : F J Pinto (Lisbon, PT), I M Pinto (Sao Paulo, BR) |
| Invasive coronary imaging | Chairperson(s) : B Merkely (Budapest, HU), E Regar (Rotterdam, NL) |